It’s going to get much more expensive to market medical devices in Canada.
Health Canada recently said that makers of Class II, III and IV devices will have to pay 75% of its costs for pre-market evaluations, 67% of right-to-sell application costs and 100% for establishment licenses. That’s up from the 43% regulatory costs the agency has been collecting from the industry.
The new fees, set to go into effect beginning on April 1, 2020, will be set at 50% to 100% of costs, with most will be phased in over four to seven years.
William K. says
Probably there will also be a huge increase in the import taxes for the folks who buy the products elsewhere. What would be interesting is to demand an explanation for the detailed reasoning behind this increase. And the truth about what lobby brought it up. Changes seldom happen without some lobby group requesting them.